相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia: The SaPPPhirE Study
Swati Agrawal et al.
HYPERTENSION (2018)
A randomized Phase III trial of neoadjuvant recombinant human endostatin, docetaxel and epirubicin as first-line therapy for patients with breast cancer (CBCRT01)
Jianghao Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model
Kana Masuda et al.
PLOS ONE (2018)
Endostar (rh-endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non-small cell lung cancer: A meta-analysis
Jihong An et al.
THORACIC CANCER (2018)
Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease
Megan Stevens et al.
GENES (2018)
VEGF-A165b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF-A splice isoforms from the kidney
Megan Stevens et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway
Xuemin He et al.
KIDNEY INTERNATIONAL (2017)
Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients
Shuji Mikami et al.
LABORATORY INVESTIGATION (2017)
Vasohibins/SVBP are tubulin carboxypeptidases (TCPs) that regulate neuron differentiation
Chrystelle Aillaud et al.
SCIENCE (2017)
Vasohibins encode tubulin detyrosinating activity
Joppe Nieuwenhuis et al.
SCIENCE (2017)
Antiangiogenic Therapy for Diabetic Nephropathy
Katsuyuki Tanabe et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Circulating soluble endoglin modifies the inflammatory response in mice
Laura Ruiz-Remolina et al.
PLOS ONE (2017)
Urinary and circulating levels of the anti-angiogenic isoform of vascular endothelial growth factor-A in patients with chronic kidney disease
Ryosuke Kikuchi et al.
CLINICA CHIMICA ACTA (2017)
The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes
Pascal Bus et al.
DIABETOLOGIA (2017)
Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling
Rie Norita et al.
CANCER SCIENCE (2017)
Age-associated downregulation of vasohibin-1 in vascular endothelial cells
Eichi Takeda et al.
AGING CELL (2016)
Overexpression of the short endoglin isoform reduces renal fibrosis and inflammation after unilateral ureteral obstruction
Jose M. Munoz-Felix et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
The association between endostatin and kidney disease and mortality in patients with type 2 diabetes
A. C. Carlsson et al.
DIABETES & METABOLISM (2016)
Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival
Mehmet Kanbay et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)
Association between levels of anti-angiogenic isoform of vascular endothelial growth factor A and pulmonary hypertension
Satoshi Suzuki et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney
Chi Hua Sarah Lin et al.
KIDNEY INTERNATIONAL (2016)
Soluble Flt-1 links microvascular disease with heart failure in CKD
Giovana S. Di Marco et al.
BASIC RESEARCH IN CARDIOLOGY (2015)
An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model
Tetsuya Nishimoto et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival
Yoshifumi Takahashi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Expression of Vasohibin-1 in Human Carotid Atherosclerotic Plaque
Ryu Fukumitsu et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
Predictive Value of Endostatin in Chronic Heart Failure Patients with Poor Kidney Function
Thor Ueland et al.
CARDIOLOGY (2015)
Tubulovascular Cross-Talk by Vascular Endothelial Growth Factor A Maintains Peritubular Microvasculature in Kidney
Henrik Dimke et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Vascular Endothelial Growth Factor-A(165)b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy
Sebastian Oltean et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Endostatin Level is Associated with Kidney Injury in the Elderly: Findings from Two Community-Based Cohorts
Toralph Ruge et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Endostatin and kidney fibrosis in aging: a case for antagonistic pleiotropy?
Chi Hua Sarah Lin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Elevated Circulating Pigment Epithelium-Derived Factor Predicts the Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes
Elaine Hui et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients
Alicia J. Jenkins et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2014)
Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease
Masaru Matsui et al.
KIDNEY INTERNATIONAL (2014)
Urinary and Plasma Levels of Vasohibin-1 Can Predict Renal Functional Deterioration in Patients with Renal Disorders
Norikazu Hinamoto et al.
PLOS ONE (2014)
Exacerbation of Diabetic Renal Alterations in Mice Lacking Vasohibin-1
Norikazu Hinamoto et al.
PLOS ONE (2014)
Elevated Soluble VEGF Receptor sFlt-1 Correlates with Endothelial Injury in IgA Nephropathy
Ya-Ling Zhai et al.
PLOS ONE (2014)
L-Endoglin Overexpression Increases Renal Fibrosis after Unilateral Ureteral Obstruction
Barbara Oujo et al.
PLOS ONE (2014)
Vasohibin-1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstruction
Hiroyuki Watatani et al.
PHYSIOLOGICAL REPORTS (2014)
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers
Alessandro Rolfo et al.
KIDNEY INTERNATIONAL (2013)
Increased Soluble Flt-1 Correlates With Delayed Graft Function and Early Loss of Peritubular Capillaries in the Kidney Graft
Marion Chapal et al.
TRANSPLANTATION (2013)
Elevated Plasma Levels of Endostatin Are Associated with Chronic Kidney Disease
Jing Chen et al.
AMERICAN JOURNAL OF NEPHROLOGY (2012)
Soluble FLT1 Binds Lipid Microdomains in Podocytes to Control Cell Morphology and Glomerular Barrier Function
Jing Jin et al.
CELL (2012)
Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy
S. Theilade et al.
DIABETIC MEDICINE (2012)
Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases
Tomokazu Ikemoto et al.
HEART AND VESSELS (2012)
Vasohibin-2 Expressed in Human Serous Ovarian Adenocarcinoma Accelerates Tumor Growth by Promoting Angiogenesis
Yoshifumi Takahashi et al.
MOLECULAR CANCER RESEARCH (2012)
Angiogenesis Inhibitor Vasohibin-1 Enhances Stress Resistance of Endothelial Cells via Induction of SOD2 and SIRT1
Hiroki Miyashita et al.
PLOS ONE (2012)
Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis
Monika Edelbauer et al.
PEDIATRIC NEPHROLOGY (2012)
VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult mice
Sebastian Oltean et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Lack of Collagen XVIII Long Isoforms Affects Kidney Podocytes, whereas the Short Form Is Needed in the Proximal Tubular Basement Membrane
Aino I. Kinnunen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Significance of Plasma Levels of Pigment Epithelium-derived Factor as Determined by Multidetector Row Computed Tomography in Pitients with Mild Chronic Kidney Disease and/or Coronary Artery Disease
Y. Shiga et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
The Vascular Marker Soluble Fms-Like Tyrosine Kinase 1 Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart Failure
Bonnie Ky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Circulating Endoglin Concentration Is Not Elevated in Chronic Kidney Disease
David M. Charytan et al.
PLOS ONE (2011)
Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis
Sayaka Maeda et al.
PHARMACOLOGICAL RESEARCH (2011)
Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis
Daisuke Saito et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Urinary Pigment Epithelium-Derived Factor as a Marker of Diabetic Nephropathy
Haibing Chen et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients
Ana M. Blazquez-Medela et al.
BMC MEDICINE (2010)
Matrix Metalloproteinase-14 (MT1-MMP)-Mediated Endoglin Shedding Inhibits Tumor Angiogenesis
Lukas J. A. C. Hawinkels et al.
CANCER RESEARCH (2010)
Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion
Yasuhiro Suzuki et al.
JOURNAL OF CELL SCIENCE (2010)
Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease
Delma Veron et al.
KIDNEY INTERNATIONAL (2010)
Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium
Ruth Olmer et al.
STEM CELL RESEARCH (2010)
VEGF-A165b Is Cytoprotective and Antiangiogenic in the Retina
Anette L. Magnussen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice
Tomoki Kosugi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Vasohibin-1 Expression in Endothelium of Tumor Blood Vessels Regulates Angiogenesis
Tomoko Hosaka et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Effects of Increased Renal Tubular Vascular Endothelial Growth Factor (VEGF) on Fibrosis, Cyst Formation, and Glomerular Disease
Samy Hakroush et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis
Hiroshi Kimura et al.
BLOOD (2009)
Reduction of Circulating Soluble Fms-Like Tyrosine Kinase-1 Plays a Significant Role in Renal Dysfunction-Associated Aggravation of Atherosclerosis
Kenji Onoue et al.
CIRCULATION (2009)
Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia
Victoria L. Bills et al.
CLINICAL SCIENCE (2009)
Vasohibin-1, a Negative Feedback Regulator of Angiogenesis, Ameliorates Renal Alterations in a Mouse Model of Diabetic Nephropathy
Tatsuyo Nasu et al.
DIABETES (2009)
Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease
Kathrin Rychli et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
The Soluble VEGF Receptor sFlt1 Contributes to Endothelial Dysfunction in CKD
Giovana S. Di Marco et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis
Yingyos Avihingsanon et al.
KIDNEY INTERNATIONAL (2009)
Endoglin haploinsufficiency reduces radiation-induced fibrosis and telangiectasia formation in mouse kidneys
Marion Scharpfenecker et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes
Ryosuke Wakusawa et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice
Ching-Hsin Ku et al.
DIABETES (2008)
The Alternatively Spliced Anti-Angiogenic Family of VEGF Isoforms VEGF(xxx)b in Human Kidney Development
Heather S. Bevan et al.
NEPHRON PHYSIOLOGY (2008)
VEGF inhibition and renal thrombotic microangiopathy
Vera Eremina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy
Joshua J. Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Expression of pigment-epithelium-derived factor during kidney development and aging
Ana Luisa Pina et al.
CELL AND TISSUE RESEARCH (2007)
Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome
Valerie Anne Schumacher et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model
K. Tanabe et al.
KIDNEY INTERNATIONAL (2007)
Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group
Luigi Schips et al.
EUROPEAN UROLOGY (2007)
PEDF induces apoptosis in human endothelial cells by activating p38 MAP kinase dependent cleavage of multiple caspases
Leiling Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2
S. Cebe Suarez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy
Sarah X. Zhang et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2006)
Endoglin regulates renal ischaemia-reperfusion injury
Neil G. Docherty et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Pigment epithetium-derived factor targets endothelial and epithelial cells in Wilms' tumor
Lisa P. Abramson et al.
JOURNAL OF PEDIATRIC SURGERY (2006)
Salutary effect of pigment epithelium-derived factor in diabetic nephropathy - Evidence for antifibrogenic activities
Joshua J. Wang et al.
DIABETES (2006)
Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin
T Shibuya et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action
J Folkman
EXPERIMENTAL CELL RESEARCH (2006)
Reduced angiogenic responses in adult endoglin heterozygous mice
M Jerkic et al.
CARDIOVASCULAR RESEARCH (2006)
Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1 (Withdrawn Publication. See vol. 298, 2021)
J Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha et al.
NATURE MEDICINE (2006)
Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: Correlation with treatment response and survival
AZ Dudek et al.
CANCER INVESTIGATION (2005)
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
NH Kim et al.
KIDNEY INTERNATIONAL (2005)
Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy
JJ Wang et al.
DIABETES (2005)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Human tumstatin land human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins
A Sudhakar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment
K Takahashi et al.
FASEB JOURNAL (2003)
Endoglin upregulation during experimental renal interstitial fibrosis in mice
A Rodríguez-Peña et al.
HYPERTENSION (2002)
Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization
K Mori et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Antiangiogenesis signals by endostatin
M Shichiri et al.
FASEB JOURNAL (2001)
分享论文
